Last updated at 08 Jul 2024 05:10 AM
Director
DIN: 08073263
Shashibhan Shukla is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at CRAYOL PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08073263.Shashibhan Shukla is currently involved in 2 different roles. Their most recent position is with CREYAL PHARMA PRIVATE LIMITED as a Director. The first company Shashibhan Shukla was appointed to as a director was CRAYOL PHARMACEUTICAL PRIVATE LIMITED. Shashibhan Shukla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Shashibhan Shukla is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at CRAYOL PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08073263.Shashibhan Shukla is currently involved in 2 different roles. Their most recent position is with CREYAL PHARMA PRIVATE LIMITED as a Director. The first company Shashibhan Shukla was appointed to as a director was CRAYOL PHARMACEUTICAL PRIVATE LIMITED. Shashibhan Shukla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| CRAYOL PHARMACEUTICAL PRIVATE LIMITED | Individual Promoter | 23-Feb-2018 |
| CRAYOL PHARMACEUTICAL PRIVATE LIMITED | Director | 23-Feb-2018 |
| CREYAL PHARMA PRIVATE LIMITED | Director | 29-Oct-2020 |
| CREYAL PHARMA PRIVATE LIMITED | Individual Promoter | 29-Oct-2020 |